deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT02566421

Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

Precision Medicine for Patients With Malignancy at the Comprehensive Cancer Center of Wake Forest University

Sponsor: National Cancer Institute (NCI)

Conditions Metastatic Neoplasm Recurrent Neoplasm Recurrent Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Unresectable Malignant Neoplasm
Interventions Laboratory Biomarker Analysis Quality-of-Life Assessment Targeted Therapy
Updated 9 times since 2017 Last updated: Jun 29, 2018 Started: Oct 31, 2015 Primary completion: Aug 31, 2017 Completion: Aug 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Assessing Feasibility

Other terminated trials from National Cancer Institute (NCI)

See all terminations from National Cancer Institute (NCI)

Other Metastatic Neoplasm trials with similar outcome

Browse all Metastatic Neoplasm trials

Listed as NCT02566421, this NA trial focuses on Metastatic Neoplasm and Recurrent Neoplasm and remains terminated or withdrawn. Sponsored by National Cancer Institute (NCI), it has been updated 9 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshotRecruiting~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshotSuspended~Jul 2017 – ~Feb 2018 · 7 months · monthly snapshotSuspended~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotTerminated~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotTerminated~Aug 2018 – ~Jan 2021 · 29 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Aug 2018 — Jan 2021 [monthly]

    Terminated NA

  5. Jun 2018 — Aug 2018 [monthly]

    Terminated NA

▶ Show 4 earlier versions

  1. Feb 2018 — Jun 2018 [monthly]

    Terminated NA

    Status: Suspended → Terminated

  2. Jul 2017 — Feb 2018 [monthly]

    Suspended NA

  3. Jun 2017 — Jul 2017 [monthly]

    Suspended NA

    Status: Recruiting → Suspended

  4. Jan 2017 — Jun 2017 [monthly]

    Recruiting NA

    First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Wake Forest University Health Sciences
Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations